Company Filing History:
Years Active: 2023-2024
Title: Inventor Estelle Marrer-Berger: Pioneering Innovations in Immunotherapy
Introduction
Estelle Marrer-Berger is an accomplished inventor based in Basel, Switzerland, known for her significant contributions to the field of immunotherapy. With a total of two patents to her name, she has been at the forefront of developing innovative solutions aimed at enhancing immune responses against cancer.
Latest Patents
Estelle’s latest patents include groundbreaking inventions in the realm of antibody technology. The first patent centers on “Antibodies binding to HLA-A2/MAGE-A4.” This invention focuses on antibodies that bind specifically to the HLA-A2/MAGE-A4 complex, including multispecific antibodies designed for activating T cells. Notably, this patent also encompasses polynucleotides that encode such antibodies and vectors and host cells that include these polynucleotides. The methods proposed in this patent aim to utilize these antibodies in disease treatment, showcasing Estelle's commitment to advancing medical therapies.
The second notable patent is for “Bispecific antigen binding molecules targeting OX40 and FAP.” This innovation details novel bispecific molecules that possess at least two antigen-binding domains capable of binding to OX40 and another domain for Fibroblast Activation Protein (FAP). The methods for producing these molecules and their potential applications further underscore Estelle’s impact in the field.
Career Highlights
Estelle Marrer-Berger currently works with Hoffmann-La Roche Inc., a leading global healthcare company. Her role involves collaborative efforts in cutting-edge research aimed at addressing complex medical challenges through innovative therapeutic approaches.
Collaborations
Throughout her career, Estelle has worked alongside esteemed colleagues, including Christian Klein and Maria Amann. These collaborations not only enhance her research initiatives but also contribute to a vibrant environment of shared knowledge and innovation within the company.
Conclusion
With her impressive portfolio of patents and collaborations, Estelle Marrer-Berger stands out as a key figure in the field of immunotherapy. Her contributions reflect a dedication to advancing treatment options for diseases, particularly cancer, and her work continues to inspire future innovations in the healthcare sector.